[Metapirone test after treatment with slow-acting tetracosactide (slow-acting synactene)].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000293:Adolescent; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D004305:Dose-Response Relationship, Drug; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008297:Male; D008797:Metyrapone; D008875:Middle Aged; D009422:Nervous System Diseases / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors
D015065:17-Hydroxycorticosteroids; D005938:Glucocorticoids; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D008797:Metyrapone
Le test à la métopirone après traitement par le tétrascosactide retard (synactène retard.